Annual Operating Profit
-$7.26 M
+$1.47 M+16.82%
31 December 2023
Summary:
ZIVO Bioscience annual operaing income is currently -$7.26 million, with the most recent change of +$1.47 million (+16.82%) on 31 December 2023. During the last 3 years, it has risen by +$1.29 million (+15.11%). ZIVO annual operating profit is now -345757.14% below its all-time high of -$2100.00, reached on 31 December 2001.ZIVO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$2.26 M
+$5.97 M+72.54%
30 September 2024
Summary:
ZIVO Bioscience quarterly operating income is currently -$2.26 million, with the most recent change of +$5.97 million (+72.54%) on 30 September 2024. Over the past year, it has dropped by -$687.60 thousand (-43.73%). ZIVO quarterly operating profit is now -1129900.00% below its all-time high of -$200.00, reached on 31 March 2001.ZIVO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$13.66 M
-$687.60 K-5.30%
30 September 2024
Summary:
ZIVO Bioscience TTM operating income is currently -$13.66 million, with the most recent change of -$687.60 thousand (-5.30%) on 30 September 2024. Over the past year, it has dropped by -$5.66 million (-70.68%). ZIVO TTM operating profit is now -2276900.00% below its all-time high of -$600.00, reached on 30 September 2000.ZIVO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.8% | -43.7% | -70.7% |
| 3 y3 years | +15.1% | -35.1% | -88.2% |
| 5 y5 years | -18.5% | -43.6% | -120.5% |
ZIVO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +16.8% | -77.1% | +72.5% | -108.0% | at low |
| 5 y | 5 years | -18.5% | +16.8% | -119.4% | +72.5% | -120.5% | at low |
| alltime | all time | <-9999.0% | +16.8% | <-9999.0% | +72.5% | <-9999.0% | at low |
ZIVO Bioscience Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.26 M(-72.5%) | -$13.66 M(+5.3%) |
| June 2024 | - | -$8.23 M(+545.1%) | -$12.97 M(+97.5%) |
| Mar 2024 | - | -$1.28 M(-32.7%) | -$6.57 M(-9.6%) |
| Dec 2023 | -$7.26 M(-16.8%) | -$1.90 M(+20.6%) | -$7.26 M(-9.3%) |
| Sept 2023 | - | -$1.57 M(-13.8%) | -$8.00 M(-5.1%) |
| June 2023 | - | -$1.82 M(-7.4%) | -$8.43 M(-2.8%) |
| Mar 2023 | - | -$1.97 M(-25.3%) | -$8.68 M(-0.6%) |
| Dec 2022 | -$8.73 M(+1.0%) | -$2.64 M(+31.9%) | -$8.73 M(-6.7%) |
| Sept 2022 | - | -$2.00 M(-3.3%) | -$9.36 M(+3.6%) |
| June 2022 | - | -$2.07 M(+2.0%) | -$9.03 M(+3.7%) |
| Mar 2022 | - | -$2.03 M(-37.9%) | -$8.71 M(-0.7%) |
| Dec 2021 | -$8.65 M(+1.0%) | -$3.26 M(+95.1%) | -$8.77 M(+20.8%) |
| Sept 2021 | - | -$1.67 M(-4.4%) | -$7.26 M(-18.9%) |
| June 2021 | - | -$1.75 M(-16.0%) | -$8.95 M(+8.7%) |
| Mar 2021 | - | -$2.08 M(+18.7%) | -$8.23 M(-3.8%) |
| Dec 2020 | -$8.56 M(+2.4%) | -$1.75 M(-47.8%) | -$8.56 M(-19.1%) |
| Sept 2020 | - | -$3.36 M(+226.7%) | -$10.57 M(+20.4%) |
| June 2020 | - | -$1.03 M(-57.2%) | -$8.78 M(-10.3%) |
| Mar 2020 | - | -$2.41 M(-36.2%) | -$9.79 M(+17.2%) |
| Dec 2019 | -$8.35 M(+36.2%) | -$3.77 M(+139.7%) | -$8.35 M(+34.8%) |
| Sept 2019 | - | -$1.57 M(-22.7%) | -$6.20 M(+1.3%) |
| June 2019 | - | -$2.04 M(+110.5%) | -$6.12 M(+13.0%) |
| Mar 2019 | - | -$967.90 K(-40.2%) | -$5.42 M(-11.7%) |
| Dec 2018 | -$6.13 M(-3.2%) | -$1.62 M(+8.2%) | -$6.13 M(-13.8%) |
| Sept 2018 | - | -$1.49 M(+12.0%) | -$7.11 M(-7.4%) |
| June 2018 | - | -$1.34 M(-20.7%) | -$7.68 M(+6.3%) |
| Mar 2018 | - | -$1.68 M(-35.2%) | -$7.22 M(+14.1%) |
| Dec 2017 | -$6.33 M(+81.4%) | -$2.60 M(+26.0%) | -$6.33 M(+44.7%) |
| Sept 2017 | - | -$2.06 M(+133.8%) | -$4.38 M(+46.2%) |
| June 2017 | - | -$881.40 K(+11.4%) | -$2.99 M(-17.8%) |
| Mar 2017 | - | -$791.30 K(+23.1%) | -$3.64 M(+4.3%) |
| Dec 2016 | -$3.49 M(+14.2%) | -$642.70 K(-5.1%) | -$3.49 M(-0.6%) |
| Sept 2016 | - | -$677.10 K(-55.7%) | -$3.51 M(-3.1%) |
| June 2016 | - | -$1.53 M(+138.9%) | -$3.62 M(+15.6%) |
| Mar 2016 | - | -$640.60 K(-3.5%) | -$3.13 M(+2.6%) |
| Dec 2015 | -$3.06 M(-18.8%) | -$663.70 K(-15.8%) | -$3.06 M(-12.1%) |
| Sept 2015 | - | -$788.30 K(-24.3%) | -$3.48 M(-8.1%) |
| June 2015 | - | -$1.04 M(+85.2%) | -$3.79 M(+6.8%) |
| Mar 2015 | - | -$562.40 K(-48.2%) | -$3.55 M(-5.8%) |
| Dec 2014 | -$3.76 M(+21.0%) | -$1.09 M(-1.0%) | -$3.76 M(+8.1%) |
| Sept 2014 | - | -$1.10 M(+36.9%) | -$3.48 M(+6.4%) |
| June 2014 | - | -$800.70 K(+2.8%) | -$3.27 M(-2.4%) |
| Mar 2014 | - | -$778.80 K(-3.2%) | -$3.35 M(+7.8%) |
| Dec 2013 | -$3.11 M(+49.5%) | -$804.30 K(-9.4%) | -$3.11 M(+13.3%) |
| Sept 2013 | - | -$888.10 K(+0.6%) | -$2.74 M(+9.4%) |
| June 2013 | - | -$882.40 K(+64.8%) | -$2.51 M(+19.0%) |
| Mar 2013 | - | -$535.30 K(+22.1%) | -$2.11 M(+1.4%) |
| Dec 2012 | -$2.08 M | -$438.30 K(-32.9%) | -$2.08 M(-20.1%) |
| Sept 2012 | - | -$653.30 K(+35.6%) | -$2.60 M(+16.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | -$481.80 K(-5.0%) | -$2.24 M(+10.8%) |
| Mar 2012 | - | -$507.20 K(-47.3%) | -$2.02 M(+4.1%) |
| Dec 2011 | -$1.94 M(-52.3%) | -$961.90 K(+237.7%) | -$1.94 M(+13.7%) |
| Sept 2011 | - | -$284.80 K(+8.0%) | -$1.70 M(-13.6%) |
| June 2011 | - | -$263.80 K(-38.4%) | -$1.97 M(-44.1%) |
| Mar 2011 | - | -$427.90 K(-41.2%) | -$3.53 M(-13.2%) |
| Dec 2010 | -$4.06 M(+53.1%) | -$727.80 K(+31.7%) | -$4.06 M(-2.4%) |
| Sept 2010 | - | -$552.80 K(-69.6%) | -$4.16 M(-9.4%) |
| June 2010 | - | -$1.82 M(+88.8%) | -$4.59 M(+48.7%) |
| Mar 2010 | - | -$962.90 K(+16.3%) | -$3.09 M(+16.4%) |
| Dec 2009 | -$2.65 M(+119.3%) | -$827.70 K(-15.8%) | -$2.65 M(+29.6%) |
| Sept 2009 | - | -$982.60 K(+213.0%) | -$2.05 M(+55.5%) |
| June 2009 | - | -$313.90 K(-40.7%) | -$1.32 M(-9.8%) |
| Mar 2009 | - | -$529.00 K(+138.7%) | -$1.46 M(+20.7%) |
| Dec 2008 | -$1.21 M(-45.8%) | -$221.60 K(-12.2%) | -$1.21 M(-15.1%) |
| Sept 2008 | - | -$252.30 K(-44.9%) | -$1.43 M(-23.6%) |
| June 2008 | - | -$457.60 K(+64.3%) | -$1.86 M(-0.4%) |
| Mar 2008 | - | -$278.50 K(-36.2%) | -$1.87 M(-16.2%) |
| Dec 2007 | -$2.23 M(-41.8%) | -$436.60 K(-36.9%) | -$2.23 M(-21.7%) |
| Sept 2007 | - | -$692.10 K(+48.8%) | -$2.85 M(+1.7%) |
| June 2007 | - | -$465.00 K(-27.5%) | -$2.80 M(-20.5%) |
| Mar 2007 | - | -$641.00 K(-39.2%) | -$3.53 M(-8.1%) |
| Dec 2006 | -$3.84 M(+20.7%) | -$1.05 M(+63.6%) | -$3.84 M(+2.5%) |
| Sept 2006 | - | -$644.40 K(-45.8%) | -$3.75 M(-20.5%) |
| June 2006 | - | -$1.19 M(+25.2%) | -$4.71 M(+21.8%) |
| Mar 2006 | - | -$950.40 K(-1.3%) | -$3.87 M(+18.6%) |
| Dec 2005 | -$3.18 M(-17.6%) | -$962.60 K(-40.3%) | -$3.26 M(+14.3%) |
| Sept 2005 | - | -$1.61 M(+364.8%) | -$2.86 M(+30.1%) |
| June 2005 | - | -$346.70 K(+0.9%) | -$2.20 M(-15.2%) |
| Mar 2005 | - | -$343.50 K(-38.1%) | -$2.59 M(-32.9%) |
| Dec 2004 | -$3.86 M(+613.3%) | -$555.20 K(-41.6%) | -$3.86 M(+0.5%) |
| Sept 2004 | - | -$950.30 K(+28.6%) | -$3.84 M(+32.9%) |
| June 2004 | - | -$739.10 K(-54.2%) | -$2.89 M(+34.3%) |
| Mar 2004 | - | -$1.61 M(+199.9%) | -$2.15 M(+297.9%) |
| Dec 2003 | -$540.80 K(>+9900.0%) | -$537.80 K(>+9900.0%) | -$540.90 K(>+9900.0%) |
| Sept 2003 | - | -$600.00(0.0%) | -$3700.00(0.0%) |
| June 2003 | - | -$600.00(-68.4%) | -$3700.00(0.0%) |
| Mar 2003 | - | -$1900.00(+216.7%) | -$3700.00(+8.8%) |
| Dec 2002 | -$3400.00(+61.9%) | -$600.00(0.0%) | -$3400.00(0.0%) |
| Sept 2002 | - | -$600.00(0.0%) | -$3400.00(0.0%) |
| June 2002 | - | -$600.00(-62.5%) | -$3400.00(0.0%) |
| Mar 2002 | - | -$1600.00(+166.7%) | -$3400.00(+70.0%) |
| Dec 2001 | -$2100.00(-41.7%) | -$600.00(0.0%) | -$2000.00(-54.5%) |
| Sept 2001 | - | -$600.00(0.0%) | -$4400.00(0.0%) |
| June 2001 | - | -$600.00(+200.0%) | -$4400.00(+15.8%) |
| Mar 2001 | - | -$200.00(-93.3%) | -$3800.00(+5.6%) |
| Dec 2000 | -$3600.00 | -$3000.00(+400.0%) | -$3600.00(+500.0%) |
| Sept 2000 | - | -$600.00(-96.1%) | -$600.00(-96.1%) |
| Sept 1999 | - | -$15.20 K | -$15.20 K |
FAQ
- What is ZIVO Bioscience annual operaing income?
- What is the all time high annual operating profit for ZIVO Bioscience?
- What is ZIVO Bioscience annual operating profit year-on-year change?
- What is ZIVO Bioscience quarterly operating income?
- What is the all time high quarterly operating profit for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly operating profit year-on-year change?
- What is ZIVO Bioscience TTM operating income?
- What is the all time high TTM operating profit for ZIVO Bioscience?
- What is ZIVO Bioscience TTM operating profit year-on-year change?
What is ZIVO Bioscience annual operaing income?
The current annual operating profit of ZIVO is -$7.26 M
What is the all time high annual operating profit for ZIVO Bioscience?
ZIVO Bioscience all-time high annual operaing income is -$2100.00
What is ZIVO Bioscience annual operating profit year-on-year change?
Over the past year, ZIVO annual operaing income has changed by +$1.47 M (+16.82%)
What is ZIVO Bioscience quarterly operating income?
The current quarterly operating profit of ZIVO is -$2.26 M
What is the all time high quarterly operating profit for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly operating income is -$200.00
What is ZIVO Bioscience quarterly operating profit year-on-year change?
Over the past year, ZIVO quarterly operating income has changed by -$687.60 K (-43.73%)
What is ZIVO Bioscience TTM operating income?
The current TTM operating profit of ZIVO is -$13.66 M
What is the all time high TTM operating profit for ZIVO Bioscience?
ZIVO Bioscience all-time high TTM operating income is -$600.00
What is ZIVO Bioscience TTM operating profit year-on-year change?
Over the past year, ZIVO TTM operating income has changed by -$5.66 M (-70.68%)